(Q73009798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

The dendritic cell and human cancer vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

2

M T Lotze

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

R M Dallal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Immunology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

583-588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

Origin, maturation and antigen presenting function of dendritic cells.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dendritic cells: a link between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Capture and processing of exogenous antigens for presentation on MHC molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Use of cellular and cytokine adjuvants in the immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Fusion induces tumour rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Report from the International Union Against Cancer (UICC) Tumor Biology Committee: UICC workshop on the use of dendritic cells in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Biology of flt3 ligand and receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Induction of dendritic cells (DC) by Flt3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

Flt3 ligand induces tumor regression and antitumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900146-1

7 January 2021

10.1016/S0952-7915(00)00146-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007363%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference